Depression and Rheumatoid Arthritis - Depression
Links shared publicly online about this topic.
- 87total visits
Depression and Rheumatoid Arthritis - Depression
View full resource at healthcentral.com
Tags: Depression, Ear, Arthritis, Rheumatoid Arthritis, Disease and Condition, Relationship, Medical
Most Recently Shared on August 8, 2011 at 9:06 pm By:
@iMesmerize Sorry to hear about your son's new diagnosis. Here is an article about depression and rheumatoid arthritis: http://bit.ly/pNGwQV
New Drug for Rheumatoid Arthritis Favored by FDA Panel - Yahoo! News
news.yahoo.com — “From Yahoo! News: For those who have rheumatoid arthritis and are just not getting any benefits from their current treatment regimen, there could be hope on the horizon. A major drug company, Pfizer, has developed a new drug that has received FDA panel favor. This does not mean that the FDA will definitely approve it.” View full resource at news.yahoo.com
Most Recently Shared on May 12, 2012 at 7:44 am By:
New Drug for Rheumatoid Arthritis Favored by FDA Panel: For those who have rheumatoid arthritis and are just not... http://t.co/QmqUK6js
FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
pharmaceuticalonline.com — “Pfizer Inc. (NYSE:PFE) announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend” View full resource at pharmaceuticalonline.com
Most Recently Shared on May 12, 2012 at 7:07 am By:
FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severe... http://t.co/soPAIfWQ
MedWire News - Bone Health - Biologics no better than DMARDs for refractory RA
medwire-news.md — “MedWire News Biologic treatment offers little long-term clinical benefit over conventional treatment for patients with rheumatoid arthritis who fail to respond to initial methotrexate therapy, Swedish researchers report. MedWire News” View full resource at medwire-news.md
Most Recently Shared on May 12, 2012 at 7:07 am By:
Biologics no better than DMARDs for refractory RA: Biologic treatment offers little long-term clinical benefit o... http://t.co/WanydNSR
Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug - Health News - redOrbit
redorbit.com — “An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.” View full resource at redorbit.com
Most Recently Shared on May 11, 2012 at 7:41 pm By:
Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug: Connie K. Ho for http://t.co/6eqBD5l3 An adv... http://t.co/d6SkusIQ
FDA Panel in Favor of First JAK Inhibitor for RA
painlive.com — “The FDA Arthritis Advisory Committee voted to recommend approval of tofacitinib, a new treatment for moderate to severe rheumatoid arthritis (RA), Pfizer announced.” View full resource at painlive.com
Most Recently Shared on May 11, 2012 at 4:00 pm By:
FDA Panel in Favor of First JAK Inhibitor for RA http://t.co/rlqs8u3o
Is it typical to be extraordinarily tired after an Enbrel injection? This is only my second self-injection, but I'm finding myself worn out. - Biologic Medications - Rheumatoid Arthritis
healthcentral.com — “Questions and answers on Rheumatoid Arthritis. Get the answers you need from doctors, Experts and community members on MyRACentral.com.” View full resource at healthcentral.com
Most Recently Shared on May 11, 2012 at 2:48 pm By:
HealthCentral Tips Health Site
Many #RA meds, including Biologics, such as Enbrel, can make you tired for a day or so after you take them http://t.co/WIe1MI4x
New rheumatoid arthritis pill tofacitinib backed by FDA panel - HealthPop - CBS News
cbsnews.com — “Pill provides alternative to injection therapies; FDA has until August to accept or reject the panel's recommendation Read more by CBS News Staff on CBS News' HealthPop.” View full resource at cbsnews.com
Most Recently Shared on May 10, 2012 at 6:32 pm By:
Arthritis OW Active Health Library and OW Health
New rheumatoid arthritis pill tofacitinib backed by FDA panel: Pill provides alternative to injection therapies;... http://t.co/dtyLmsf4
Is Obesity Causing a Rise in Rheumatoid Arthritis Among Women? | Healthland | TIME.com
healthland.time.com — “A recent study by Mayo Clinic researchers suggests that rheumatoid arthritis may belong on the growing list of health risks associated with obesity, especially among women.” View full resource at healthland.time.com
Most Recently Shared on May 10, 2012 at 1:36 pm By:
Is Obesity Causing a Rise in Rheumatoid Arthritis Among Women?: A recent study by Mayo Clinic researchers sugges... http://t.co/1aVPy3aO
FEDERAL PANEL BACKS NOVEL ARTHRITIS DRUG | UTSanDiego.com
utsandiego.com — “A federal advisory panel recommended approval Wednesday of a rheumatoid arthritis pill that could offer patients an alternative to the injectable medicines already on the market, but several members expressed concern about safety and urged the Food and Drug Administration to require rigorous follow-up studies.” View full resource at utsandiego.com
Most Recently Shared on May 10, 2012 at 1:36 pm By:
FEDERAL PANEL BACKS NOVEL ARTHRITIS DRUG: A federal advisory panel recommended approval Wednesday of a rheumatoi... http://t.co/8GDxh96A
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval - NYTimes.com
nytimes.com — “A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.” View full resource at nytimes.com
Most Recently Shared on May 10, 2012 at 1:09 pm By:
Dr. Shashank Akerkar Doctor, Internist, Rheumatologist, and Physician
#Arthritis Pill From Pfizer Wins Support Of U.S. Panel http://t.co/hm0jHkP1 #rheum
Is Obesity Causing a Rise in Rheumatoid Arthritis Among Women? | Healthland | TIME.com
healthland.time.com — “A recent study by Mayo Clinic researchers suggests that rheumatoid arthritis may belong on the growing list of health risks associated with obesity, especially among women.” View full resource at healthland.time.com
Most Recently Shared on May 10, 2012 at 12:31 pm By:
Obesity and Arthritis: A Link Among Women?: * http://t.co/DjET2hZj
A second opinion
ronankavanagh.ie — “In my first few months working as a rheumatologist a referral letter arrived from a local doctor about a lady with rheumatoid arthritis. She had recently m” View full resource at ronankavanagh.ie
Most Recently Shared on May 10, 2012 at 9:35 am By:
Dr. Shashank Akerkar Doctor, Internist, Rheumatologist, and Physician
RT @RonanTKavanagh The humbling art of medicine. A second opinion. http://t.co/QwN1BPNo /// NIce one Ronan...
Autoimmunity In Rheumatoid Arthritis Tempered By Regulatory Immune Cell Diversity
medicalnewstoday.com — “Untangling the root cause of rheumatoid arthritis has been a difficult task for immunologists, as decades of research has pointed to multiple culprits in our immune system, with contradictory line” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2012 at 8:05 am By:
MNT Arthritis News Health News
Autoimmunity In Rheumatoid Arthritis Tempered By Regulatory Immune Cell Diversity http://t.co/i2dd88Pu #arthritis
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval - NYTimes.com
nytimes.com — “A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.” View full resource at nytimes.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
Pfizer’s Rheumatoid Arthritis Pill Wins Federal Panel’s Approval: A federal advisory panel recommended approval ... http://t.co/s1MJUD0v
FDA panel favors Pfizer's new arthritis drug - Health - Aging - msnbc.com
msnbc.msn.com — “Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term side effects.” View full resource at msnbc.msn.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
Panel backs new arthritis drug: >> michael collins , a former trader on the chicago commodities exchange , is in... http://t.co/dcO2IvI0
Advertisement
